Prolocor: Funding, Investors & Team (Aug 2026)
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.
Prolocor has raised $3.2M across 1 funding round on record, the most recent a Seed of $3.2M announced in Aug 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Prolocor Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Prolocor Funding Rounds
Prolocor Founders and Leadership Team
No contact details are on record for this team yet.
Prolocor Funding Compared to Other Biotechnology Startups
Prolocor's latest round of $3.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Prolocor in Biotechnology and Philadelphia
Companies Similar to Prolocor
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Prolocor Funding FAQs
What does Prolocor do?
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.
How much funding has Prolocor raised?
Prolocor has raised $3.2M across 1 round on record. The most recent is a Seed of $3.2M announced in Aug 2022.
When did Prolocor last raise funding?
Prolocor's most recent funding round on record is a Seed of $3.2M, announced in Aug 2022.
Who is the CEO of Prolocor?
Peter Dibattiste is listed as CEO at Prolocor.
Where is Prolocor headquartered?
Prolocor is based in Philadelphia, Pennsylvania, United States.
How many employees does Prolocor have?
Prolocor is in the 1-10 employee band.
How does Prolocor's funding compare to other Biotechnology startups?
Prolocor's latest round of $3.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Prolocor Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prolocor is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.